Refine by:
-
Congressional Testimony on Mental Health Funding, Crisis Services, and Research and Treatment Innovation
Outside Witness Testimony from NAMI’s Chief Advocacy Officer to the Senate Subcommittee on Labor, Health and Human Services, Education and Related Agencies, requesting FY26 funding for 988 and the Community Mental Health Block Grant within SAMHSA and NIMH. -
Regulatory Comment on Medicare and Research and Treatment Innovation
NAMI regulatory comment encouraging CMS to implement a star rating system that prioritizes patient experience as part of the Inpatient Psychiatric Facilities Quality Reporting Program. -
Letter to Congressional Leadership on Research and Treatment Innovation and Mental Health Funding
Letter urging the House and Senate Labor-HHS Subcommittees and the Agriculture Committee to prioritize SAMHSA’s Center of Excellence for Eating Disorders, the HHS Office on Women’s Health, and eating disorders prevention for FY26. -
Patient and Staff Experiences with Telehealth for Suicide Prevention in the Emergency Department
To understand whether telehealth could help supplement emergency department (ED) resources, researchers implemented the Telehealth to Improve Prevention of Suicide (TIPS) program in two Massachusetts EDs and analyzed patient and staff feedback.
-
Letter to Congressional Bill Sponsors on Research and Treatment Innovation
Letter to bill sponsors in support of the COMPLETE Care Act (S.931/H.R.2509), legislation that would improve access to timely and effective behavioral health care treatment by incentivizing primary care to adopt, implement and progress along the integrated care continuum. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter to leaders of House and Senate Appropriation Committees to provide $35 million for the CDC, $25 million for the NIH, and $1 million for the NIJ for critical gun violence prevention research. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter to Congressional leaders, urging greater transparency and oversight regarding potential federal agency Reduction-in-Force and reorganization plans that would impact our nation’s scientific enterprise and public health infrastructure. -
Insurance Status and Mental Health Care during the COVID-19 Pandemic
According to new research analyzing data from the Mental and Substance Use Disorder Prevalence Study, which took place during the first two years of the COVID-19 pandemic, adults with a mental health diagnosis and no insurance were less likely to have received outpatient mental health treatment in the past year compared to privately insured adults – just 31% versus 62%.
-
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter calling on House and Senate appropriators to reject the proposed cuts to the Department of Health and Human Services (HHS), including the National Institutes of Health, that were included in the leaked copy of the HHS FY 2026 budget “Passback” document. -
Letter to Congressional Committee Leadership on Research and Treatment Innovation and Mental Health Funding
Letter urging Congress to robustly fund NIH at least $51.303 billion for FY 26.